Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tasigna
Pharma
Novartis will let generic Tasigna to be provided to poor nations
The Medicines Patent Pool has signed up four generic drugmakers to produce copycats of Novartis’ myeloid leukemia drug Tasigna for poorer nations.
Kevin Dunleavy
Jun 23, 2023 10:01am
BMS, Novartis, Roche join new coalition for cancer drug access
May 20, 2022 10:50am
Novartis wins CML nod for new Gleevec follow-on Scemblix
Nov 1, 2021 6:51am
'Audacious' CVS drops key meds from Sanofi, Novartis and more
Aug 3, 2016 6:22am